The stock had created a descending triangle pattern but with the strength of their earnings report, it broke out of the pattern. We will have to see how it settles over the next couple of days to figure out where it is going from here.
Indicators all bullish pre earnings and a possible noteworthy reversal on the cards. Like all BIO stocks there is always a risk of negative news related moves. Average analysts price target $93 | Overweight. Oct 16th Incyte reports positive results for late stage trial in GVHD drug. Company profile Incyte Corp. is a biopharmaceutical company, which engages in the...
INCY is rated "strong buy" doesn't mean too much, but price is showing signs of an overall oscillating pattern with peaks forming near a common RSI level around 60. Price is also trading above the SMA200 on the daily chart, signaling potential bullish movement. Friday's close created a large Bullish Candlestick that broke above & closed above both the SMA50 and...
INCY has been sideways for a year, but it is not showing a compression candlestick pattern to a potential Triangle Formation. Triangles tend to be continuation patterns much of the time.
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute...
Fundamentally nothing much has changed in INCY recently but technically the stock is reaching a point of decision, is the correction? can we go higher? we are biased towards a break higher as indicators are improving while the price gets squeezed between they 100 and 200ma. The $82 region may be a good area to look for a long on a break from converging...
SMA and EMA crossed. MACD crossed. The technical setup is looking very nice assuming you get a decent entry. Stop Loss: $77.29 Exit 1: $72.27 Exit 2: $68.02
Incyte Corp. has overlapping white candles on a strong move out of a short-term bottom. The overlaps are caused by pre-market open selling that gaps the stock down. The run up shows strength within the buy side.
The prices are making a pullback on the 200 daily SMA. The IN area in my opinion is the green box with tight stop loss due the RSI value. From the green box LONG until the prices will be on the 200 daily SMA